Clinical therapeutics
-
Clinical therapeutics · Apr 2011
Randomized Controlled Trial Multicenter StudyEffects of varenicline in adult smokers: a multinational, 24-week, randomized, double-blind, placebo-controlled study.
Prevalence rates of smoking are rising in developing countries. Previous trials evaluating the efficacy and tolerability of the smoking-cessation medication varenicline have used largely participants of Caucasian origin. ⋯ Based on these data, varenicline was apparently efficacious and generally well tolerated as a smoking-cessation aid in smokers from selected sites in Latin America, Africa, and the Middle East. ClinicalTrials.gov identifier: NCT00594204.